Liver cancer study gives doctors and patients more info on treatment options

For a long time, patients with intermediate-stage liver cancer, where the tumour is too large to be removed with surgery, had no clear data on which treatment worked best. One type of treatment directs tiny radioactive spheres to the tumour, while the other is an oral medication - sorafenib - that must be taken as long as the body can bear the side effects. But after seven years of research, a team from Singapore led by National Cancer Centre Singapore

Opioid Substitutes Do Not Impede Hep C Combo Drugs

SAN FRANCISCO — For patients with hepatitis C who are receiving opioid substitutes, the once-daily single-tablet combination of sofosbuvir plus ledipasvir (Harvoni Gilead Sciences) is well tolerated and effective, according to an analysis of data from the phase 3 ION studies."As long as you anticipate drug interactions, opiate therapy should not prevent treatment," said Nancy Reau, MD, from Rush University Medical Center in Chicago, who presented the findi